Per Dr. Chandler Marrs (who runs www.hormonesmatter.com), “Above and around genetic codes reside the on/off switches to many processes (the switching of genes on and off is epigenetics). If common medications, including fluoroquinolones, up or downregulate these processes and create new diseases, what is someone who takes them supposed to do? Can epigenetic changes be reversed? What is the patient to do with all the recent research on epigenetics? The research is all well and good, but what does it mean to the patient?”
Here is a post about how fluoroquinolones, and other common pharmaceuticals, affect epigenetics. There are currently more questions than answers and the right path is far from clear.
Fluoroquinolone toxicity affects everyone differently. Why? Because that’s how mitochondrial dysfunction works. WHY? Because mitochondrial produced ROS influence gene expression and we all have different genes. WHAT? Yup, ROS affect gene expression. Perhaps we should be more careful with our mitochondria. After all, our genes are at stake.
Same Disease, Different Symptoms: It’s all in the Mitochondria
Fun facts – Nalidixic acid, the chemical compound that is the base of all fluoroquinolones, was discovered in 1962. Mitochondrial DNA was discovered in 1967 (by Lynn Margulis who happened to be married to Carl Sagan). So, if you are under the impression that naladixic acid was tested for its affects on mitochondrial DNA, you would be wrong. Information regarding how mitochondria affect gene expression is being uncovered… um… now-ish. So, in the 30+ years that fluoroquinolones have been pushed, they have been used by the human population with zero knowledge of how they affect gene expression (both mitochondrial and nuclear). Gene expression, as you might imagine, is important.
More information can be found in this post, “Your Mighty Mitochondria” published on Hormones Matter: